Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | AZN | AMGN | GILD | VRTX |
| Company | Regeneron Pharmaceuticals | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 736.00 | 89.68 | 327.99 | 124.00 | 440.48 |
| High | 736.00 | 89.68 | 327.99 | 124.00 | 440.48 |
| Low | 736.00 | 89.68 | 327.99 | 124.00 | 440.48 |
| Latest | 736.00 | 89.68 | 327.99 | 124.00 | 440.48 |
| Change | +2.22 | -0.26 | -3.01 | -0.14 | -1.60 |
| % Change | +0.30% | -0.29% | -0.91% | -0.11% | -0.36% |
| Volume | 466 | 109,154 | 5,044 | 4,162 | 996 |
| 20-Day Average Volume | 752,888 | 7,664,903 | 2,090,067 | 5,354,128 | 1,141,725 |
| Previous Close | 733.78 | 89.94 | 331.00 | 124.14 | 442.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 770.56 | 93.00 | 329.50 | 123.03 | 456.35 |
| 20-Day Raw Stochastic | 17.15% | 6.95% | 39.37% | 67.62% | 19.62% |
| 20-Day Relative Strength | 47.80 | 45.66 | 50.88 | 52.35 | 46.42 |
| Weighted Alpha | +18.74 | +30.53 | +19.57 | +29.24 | +1.04 |
| Today's Opinion | 56% Buy | 56% Buy | 48% Buy | 72% Buy | 40% Buy |
| Previous Opinion | 56% Buy | 64% Buy | 80% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 72% Buy | 56% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.02% since 01/13/26 | -5.11% since 01/13/26 | +1.14% since 01/13/26 | +1.84% since 01/13/26 | -3.12% since 01/13/26 |
| Low | 718.38 on 01/20/26 | 89.17 on 01/20/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 429.00 on 01/20/26 |
| High | 766.64 on 01/14/26 | 96.43 on 01/14/26 | 333.03 on 01/16/26 | 126.24 on 01/20/26 | 455.03 on 01/14/26 |
| 1-Month | |||||
| %Chg | -4.16% since 12/19/25 | -1.84% since 12/19/25 | +0.19% since 12/19/25 | -0.23% since 12/19/25 | -3.44% since 12/19/25 |
| Low | 718.38 on 01/20/26 | 89.17 on 01/20/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 821.11 on 01/09/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +27.04% since 10/21/25 | +7.76% since 10/21/25 | +8.92% since 10/21/25 | -0.06% since 10/21/25 | +3.33% since 10/21/25 |
| Low | 572.75 on 10/23/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 821.11 on 01/09/26 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +34.91% since 07/21/25 | +30.50% since 07/21/25 | +10.86% since 07/21/25 | +14.52% since 07/21/25 | -3.93% since 07/21/25 |
| Low | 541.00 on 10/13/25 | 69.42 on 07/22/25 | 269.77 on 09/26/25 | 108.06 on 07/22/25 | 362.50 on 08/11/25 |
| High | 821.11 on 01/09/26 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 77,119,536 | 278,977,344 | 178,237,216 | 154,018,016 | 112,164,088 |
| Shares Outstanding, K | 105,099 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 14,202,000,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 4,412,600,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 3,754,300,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | 1,460,000,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.39 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | 11.83 on 10/28/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 01/30/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | 0.880 on 11/20/25 | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | 11/20/25 | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 19.98 | 20.65 | 15.11 | 15.25 | 28.83 |